Harrigan PR - Search Results

1

Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada.

Jacka B, Applegate T, Krajden M, Olmstead A, Harrigan PR, Marshall B, DeBeck K, Milloy MJ, Lamoury F, Pybus OG, Lima VD, Magiorkinis G, Montoya V, Montaner J, Joy J, Woods C, Dobrer S, Dore GJ, Poon AF, Grebely J. Jacka B, et al. Among authors: harrigan pr. Hepatology. 2014 Nov;60(5):1571-1580. doi: 10.1002/hep.27310. Epub 2014 Sep 29. Hepatology. 2014. PMID: 25042607 Free PMC article.

2

Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach.

Jacka B, Bray BC, Applegate TL, Marshall BDL, Lima VD, Hayashi K, DeBeck K, Raghwani J, Harrigan PR, Krajden M, Montaner JSG, Grebely J Senior. Jacka B, et al. Among authors: harrigan pr. J Viral Hepat. 2018 Jan;25(1):28-36. doi: 10.1111/jvh.12758. Epub 2017 Sep 4. J Viral Hepat. 2018. PMID: 28719060 Free PMC article.

3

Development and Validation of Two Screening Assays for the Hepatitis C Virus NS3 Q80K Polymorphism Associated with Reduced Response to Combination Treatment Regimens Containing Simeprevir.

Chui CK, Dong WW, Joy JB, Poon AF, Dong WY, Mo T, Woods CK, Beatty C, Hew H, Harrigan PR, Brumme CJ. Chui CK, et al. Among authors: harrigan pr. J Clin Microbiol. 2015 Sep;53(9):2942-50. doi: 10.1128/JCM.00650-15. Epub 2015 Jul 1. J Clin Microbiol. 2015. PMID: 26135875 Free PMC article.

4

An assessment of the relationship between the World Health Organization HIV drug resistance early warning indicators and HIV drug resistance acquisition.

St-Jean M, Harrigan PR, Sereda P, Montaner J, Lima VD. St-Jean M, et al. Among authors: harrigan pr. HIV Med. 2017 May;18(5):342-353. doi: 10.1111/hiv.12435. Epub 2016 Oct 4. HIV Med. 2017. PMID: 27704659 Free article.

5

Rates of new infections in British Columbia continue to decline at a faster rate than in other Canadian regions.

Hogg RS, Nosyk B, Harrigan PR, Lima VD, Chan K, Heath K, Wood E, Kerr T, Montaner JS. Hogg RS, et al. Among authors: harrigan pr. HIV Med. 2013 Oct;14(9):581-2. doi: 10.1111/hiv.12079. HIV Med. 2013. PMID: 24033869 Free PMC article. No abstract available.

6

Performance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals.

Gonzalez-Serna A, Min JE, Woods C, Chan D, Lima VD, Montaner JS, Harrigan PR, Swenson LC. Gonzalez-Serna A, et al. Among authors: harrigan pr. Clin Infect Dis. 2014 Apr;58(8):1165-73. doi: 10.1093/cid/ciu019. Epub 2014 Jan 14. Clin Infect Dis. 2014. PMID: 24429436 Free PMC article.

7

Longitudinal trends of HIV drug resistance in a large Canadian cohort, 1996-2016.

Rocheleau G, Brumme CJ, Shoveller J, Lima VD, Harrigan PR. Rocheleau G, et al. Among authors: harrigan pr. Clin Microbiol Infect. 2018 Feb;24(2):185-191. doi: 10.1016/j.cmi.2017.06.014. Epub 2017 Jun 23. Clin Microbiol Infect. 2018. PMID: 28652115 Free article.

8

Superior virological response to boosted protease inhibitor-based highly active antiretroviral therapy in an observational treatment programme.

Wood E, Hogg RS, Yip B, Moore D, Harrigan PR, Montaner JS. Wood E, et al. Among authors: harrigan pr. HIV Med. 2007 Mar;8(2):80-5. doi: 10.1111/j.1468-1293.2007.00430.x. HIV Med. 2007. PMID: 17352763 Free article.

9

HIV protease and reverse transcriptase variation and therapy outcome in antiretroviral-naive individuals from a large North American cohort.

Alexander CS, Dong W, Chan K, Jahnke N, O'Shaughnessy MV, Mo T, Piaseczny MA, Montaner JS, Harrigan PR. Alexander CS, et al. Among authors: harrigan pr. AIDS. 2001 Mar 30;15(5):601-7. doi: 10.1097/00002030-200103300-00009. AIDS. 2001. PMID: 11316997

10

Performance of a World Health Organization first-line regimen (stavudine/lamivudine/nevirapine) in antiretroviral-naïve individuals in a Western setting.

Tam LW, Hogg RS, Yip B, Montaner JS, Harrigan PR, Brumme CJ. Tam LW, et al. Among authors: harrigan pr. HIV Med. 2007 Jul;8(5):267-70. doi: 10.1111/j.1468-1293.2007.00463.x. HIV Med. 2007. PMID: 17561871 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

321 results

Search Page